CD19 and myeloid sarcoma: Analysis of repertoire diversity of the light chains showed that in the HDs the ratio in number of the IGK and IGL clonotypes in the total CD19+ pool was higher than in tBregs, whereas it remained unchanged in MS patients (Figure 2B).